U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty
BUZZ-U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty August 28 (Reuters) - Futures tied to the S&P 500 and Nasdaq inched lower on Friday after Nvidia's stellar forecast sparked a technology rally in the previous session, while markets awaited Federal Reserve Chair Kevin Warsh's much-anticipated Jackson Hole appearance. .N
** Gap Inc GAP.N:
BUZZ - Gains on Old Navy CEO pick, higher profit forecast nL6N44P0GV
** Autodesk Inc ADSK.O:
BUZZ - Falls on weak profit forecast nL4N44P0K6
** BioXcel Therapeutics Inc BTAI.O:
BUZZ - Falls after filing for Chapter 11 bankruptcy nL6N44P0IV
** Affirm Holdings Inc AFRM.O:
BUZZ - Jumps as revenue forecast exceeds estimates nL6N44P0HT
** Solstice Advanced Materials Inc SOLS.O:
BUZZ - Rises after scrapping $14.5 billion merger with Element nL4N44P0N3
** PayPal Holdings Inc PYPL.O:
BUZZ - Tumbles after report Advent-Stripe consortium drops takeover pursuit
nL6N44P0I5
** Take-Two Interactive Software Inc TTWO.O:
BUZZ - Gains after GTA VI preview nL4N44P0OD
** Iren Ltd IREN.O:
BUZZ - Falls as AI transition costs drive quarterly loss nL6N44P0K8
** Ulta Beauty Inc ULTA.O:
BUZZ - Down after posting slower comparable sales growth nL6N44P0II
** Quoin Pharmaceuticals Ltd QNRX.O:
BUZZ - Surges on promising trial data for rare skin disease, $50 million financing nL4N44P0RS
** Cytokinetics Inc CYTK.O:
BUZZ - Rises after heart disease drug shows promise in late-stage study nL6N44P0KY
** Moderna Inc MRNA.O:
BUZZ - Rises after upsized $2.6 bln convertible bond sale nL6N44P0MB
** SentinelOne Inc S.N:
BUZZ - Falls on weak annual profit forecast nL6N44P0LJ
(Rajarshi Roy and Koyena Das)
Recent news on The Gap
See all newsAmerican Eagle shares slump on flat margin outlook, weakness in namesake brand (updated)
American Eagle shares slide as flat margin outlook, weak core brand weigh
Street View: Gap shines despite Old Navy stumble
U.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics